NCT00939562View on ClinicalTrials.gov

Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate

PHASE4CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Bacterial Infection

Interventions

DRUG

doxycycline monohydrate tablet

Tablet, 100 mg, Single dose

DRUG

doxycycline carragenate tablet

Tablet, 100 mg, Single dose

Trial Locations (1)

380 015

Pfizer Investigational Site, Ahmedabad

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT00939562 - Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate | Biotech Hunter | Biotech Hunter